| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.053 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |